Detalles de la búsqueda
1.
Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in France.
Vaccine
; 41(13): 2280-2288, 2023 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36870880
2.
Severe hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants in France, December 2021-January 2022: A retrospective, population-based, matched cohort study.
EClinicalMedicine
; 48: 101455, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35611065
Resultados
1 -
2
de 2
1
Próxima >
>>